Navigation Links
Report Highlights Key Activities that Drive Successful New Product Planning Groups in Pharmaceutical Industry
Date:8/24/2012

CHAPEL HILL, N.C., Aug. 24, 2012 /PRNewswire/ -- New Product Planning is called many things - New Product Commercialization, New Product Development, or just Commercial Planning. While the new product planning function goes by many names, those working in the role are all seeking the same result: successful product commercialization.

Some 3,000 medicines are in development in the United States for roughly 4,000 different indications. Still, the industry is grappling with depleted pipelines, fewer approvals and rising development costs. Understandably, the New Product Planning (NPP) function is under increasing pressure to perform and thus the function has found itself becoming involved earlier and earlier in the development cycle.

A new data-rich benchmarking study from research and consulting firm Best Practices, LLC delivers actionable insights on the critical elements of the new product planning (NPP) function. The study, Driving Growth through Planning, Structure and Activities: Best Practices in Pharmaceutical New Product Planning, identifies the full set of activities that NPP groups perform across the development cycle. Beyond examining the timing and reasons behind critical New Product Planning activities, this 72-page written report delves into how the function's structure and interactions with other functions play a role in its influence.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at leading organizations.

Topics covered in this study include:

- NPP Group Structures, Roles and Responsibilities
- Interactions and Optimal Working Relationships between Regional and Global NPP Groups
- Examining the Full Set of Activities NPP Groups Perform, their timing, intended outcomes and value

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1173.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report: Independent Drugstores, Policymakers Face New Challenges
2. Companion Diagnostics and Personalized Medicine Market Report 2012: Twease.org
3. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
4. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
5. MGC Diagnostics Corporation to Report Third Quarter Fiscal 2012 Financial Results on Thursday, August 30, 2012
6. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
7. Concord Medical Reports Second Quarter 2012 Financial Results
8. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
9. Organovo Reports Q2 2012 Financial Results, Provides Business Update
10. ULURU Inc. Reports Second Quarter 2012 Financial Results
11. China Pharma Holdings, Inc. Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
(Date:9/5/2017)... announced another milestone in their continued growth and success of the company.  Xyntek ... customer engagements regionally.  ... located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support ... In addition to Xyntek,s ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( ... with the latest Artificial Intelligence (AI) thinking, announced today the launch of its ... access to essential information that offers a more comprehensive understanding of the organization’s ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Doctors on ... to their qualified network of medical professionals working on a personal injury lien basis. ... Spine Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that Clear ... commercial support services market) has entered into an agreement on September 1, 2017 ... The PGSD is the first private Dental School to launch an online, accredited ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going on ... positive feedback from customers trying the product for the first time, and others who ... developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from multiple ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Americans at risk of price gouging for their prescription drugs, according to a ... “Because Medicare isn’t negotiating on our behalf, there’s no consistency in drug pricing ...
Breaking Medicine News(10 mins):